India Thalassemia Market Research Report Forecast to 2032
India Thalassemia Market is anticipated to register a CAGR of 5.19% during the review period. Thalassemia is a genetic blood condition in which the human body produces an abnormal kind of haemoglobin. It causes a huge number of blood cells to be destroyed, resulting in anaemia. Thalassemia is a genetic condition caused by the deletion or modification of a specific gene segment. If only one parent carries the gene, the child may get thalassemia mild. If both parents are chronic carriers, the child may acquire a severe version of the disease.
The growing government initiatives and support to raise awareness for thalassemia and the increased prevalence of thalassemia in India are major factors driving the growth of the Indian thalassemia market. However, the side effects associated with thalassemia drug treatment are expected to hamper the growth of the Indian market. Nevertheless, the advancements in prenatal and newborn screening technologies are anticipated to create lucrative opportunities for the players operating in the Indian market.
Market Segmentation
Based on type, the India thalassemia market has been bifurcated into alpha-thalassemia and beta-thalassemia.
On the basis of treatment & diagnosis, the India thalassemia market is segmented into treatment & diagnosis. diagnosis further segment into instruments and reagents.
Major Players
The key companies operating in India Thalassemia market are Cadila Pharmaceuticals, Centruion Remedies Private Limited, Agios Pharmaceuticals, Inc., Cipla Inc, Healing Pharma India Pvt. Ltd. (HPIPL), Rewine Pharmaceutical, Trexgen Pharmaceuticals Pvt. Ltd., Novartis AG, Bristol-Myers Squibb, and Sun Pharmaceutical Industries Ltd.
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.6 Approaches For Market Size Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.7 Data Forecasting
- 3.7.1 Data Forecasting Technique
- 3.8 Data Modelling
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modelling:
- 3.9 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Growing Government Initiatives And Support To Raise Awareness For Thalassemia
- 4.2.2 Increased Prevalence Of Thalassemia In India
- 4.3 Restraints
- 4.3.1 Side Effects Associated With Thalassemia Drug Treatment
- 4.4 Opportunity
- 4.4.1 Launch Of Services With Advancements In Prenatal And Newborn Screening Technologies
- 5 Market Factor Analysis
- 5.1 Porter's Five Forces Model
- 5.1.1 Threat Of New Entrants
- 5.1.2 Bargaining Power Of Suppliers
- 5.1.3 Threat Of Substitutes
- 5.1.4 Bargaining Power Of Buyers
- 5.1.5 Intensity Of Rivalry
- 5.2 Impact Of Covid-19 On The India Thalassemia Market
- 6 India Thalassemia Market, By Type
- 6.1 Introduction
- 7 India Thalassemia Market, By Treatment & Diagnosis
- 7.1 Introduction
- 7.2 Treatment
- 7.3 Diagnosis
- 8 Competitive Landscape
- 8.1 Introduction
- 8.2 Market Share Analysis, 2022
- 8.3 Competitor Dashboard
- 8.4 Public Players Stock Summary
- 8.5 Comparative Analysis: Key Players Finanical
- 8.6 Key Developments & Growth Strategies
- 8.6.1 Product Launch
- 9 Company Profiles
- 9.1 Cadila Pharmaceuticals
- 9.1.1 Company Overview
- 9.1.2 Financial Overview
- 9.1.3 Products Offered
- 9.1.4 Key Developments
- 9.1.5 Swot Analysis
- 9.1.6 Key Strategies
- 9.2 Agios Pharmaceuticals, Inc
- 9.2.1 Company Overview
- 9.2.2 Financial Overview
- 9.2.3 Products Offered
- 9.2.4 Key Developments
- 9.2.5 Key Strategies
- 9.3 Cipla Inc
- 9.3.1 Company Overview
- 9.3.2 Financial Overview
- 9.3.3 Products Offered
- 9.3.4 Key Developments
- 9.3.5 Key Strategies
- 9.4 Novartis Ag
- 9.4.1 Company Overview
- 9.4.2 Financial Overview
- 9.4.3 Products Offered
- 9.4.4 Key Developments
- 9.4.5 Swot Analysis
- 9.4.6 Key Strategies
- 9.5 Centurion Remedies Private Limited
- 9.5.1 Company Overview
- 9.5.2 Financial Overview
- 9.5.3 Products Offered
- 9.5.4 Key Developments
- 9.5.5 Key Strategies
- 9.6 Healing Pharma India Pvt. Ltd.
- 9.6.1 Company Overview
- 9.6.2 Financial Overview
- 9.6.3 Products Offered
- 9.6.4 Key Developments
- 9.6.5 Key Strategies
- 9.7 Rewine Pharmaceutical
- 9.7.1 Company Overview
- 9.7.2 Financial Overview
- 9.7.3 Products Offered
- 9.7.4 Key Developments
- 9.7.5 Key Strategies
- 9.8 Sun Pharmaceutical Industries Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Overview
- 9.8.3 Products Offered
- 9.8.4 Key Developments
- 9.8.5 Swot Analysis
- 9.8.6 Key Strategies
- 9.9 Bristol-myers Squibb Company
- 9.9.1 Company Overview
- 9.9.2 Financial Overview
- 9.9.3 Products Offered
- 9.9.4 Key Developments
- 9.9.5 Swot Analysis
- 9.9.6 Key Strategies
- 9.10 Trexgen Pharmaceuticals Pvt. Ltd.
- 9.10.1 Company Overview
- 9.10.2 Financial Overview
- 9.10.3 Products Offered
- 9.10.4 Key Developments
- 9.10.5 Key Strategies
- 10 Data Citations
- List Of Tables
- Table 1 Qfd Modelling For Market Share Assessment
- Table 2 India Thalassemia Market, By Type, 2019–2032 (Usd Million)
- Table 3 India Thalassemia Market, By Treatment & Diagnosis, 2019–2032 (Usd Million)
- Table 4 India Thalassemia Market, For Treatment, By Type 2019–2032 (Usd Million )
- Table 5 India Thalassemia Market, For Diagnosis, By Type 2019–2032 (Usd Million)
- Table 6 India Thalassemia Market, For Diagnosis, By Type 2019–2032 (Volume Units)
- Table 7 India Thalassemia Market, For Instruments, By Type 2019–2032 (Volume Units)
- Table 8 India Thalassemia Market, For Reagents, By Type 2019–2032 (Volume Units)
- Table 9 Public Players Stock Summary
- Table 10 Comparative Analysis: Key Players Finanical
- Table 11 Product Launch
- Table 12 Cadila Pharmaceuticals: Product Offered
- Table 13 Agios Pharmaceuticals, Inc: Product Offered
- Table 14 Agios Pharmaceuticals, Inc: Key Developments
- Table 15 Cipla Inc: Product Offered
- Table 16 Novartis Ag: Products Offered
- Table 17 Centurion Remedies Private Limited: Products Offered
- Table 18 Healing Pharma India Pvt. Ltd.: Products Offered
- Table 19 Rewine Pharmaceutical: Products Offered
- Table 20 Sun Pharmaceutical Industries Ltd.: Financial Overview
- Table 21 Sun Pharmaceutical Industries Ltd.: Products Offered
- Table 22 Bristol-myers Squibb Company: Prodcuts Offered
- Table 23 Trexgen Pharmaceuticals Pvt. Ltd.: Products Offered
- List Of Figures
- Figure 1 India Thalassemia Market: Structure
- Figure 2 India Thalassemia Market Report: Market Growth Factor Analysis (2022-2032)
- Figure 3 Driver Impact Analysis (2023-2032)
- Figure 4 Restraint Impact Analysis (2022-2032)
- Figure 5 Porter's Five Forces Analysis: India Thalassemia Market
- Figure 6 India Thalassemia Market; Type Segment Attractiveness, (Usd Million)
- Figure 7 India Thalassemia Market, By Type, 2022 & 2032 (Usd Million)
- Figure 8 India Thalassemia Market Share (%), By Type, 2022
- Figure 9 India Thalassemia Market; Treatment Segment Attractiveness, (Usd Million)
- Figure 10 India Thalassemia Market, By Treatment, 2022 & 2032 (Usd Million)
- Figure 11 India Thalassemia Market Share (%), By Treatment & Diagnosis, 2022
- Figure 12 India Thalassemia Market Players: Competitive Analsis, 2022
- Figure 13 Competitor Dashboard: India Thalassemia Market
- Figure 14 Cadila Pharmaceuticals: Financial Overview Snapshot
- Figure 15 Cadila Pharmaceuticals: Swot Analysis
- Figure 16 Agios Pharmaceuticals, Inc.: Financial Overview Snapshot
- Figure 17 Cipla Inc: Financial Overview Snapshot
- Figure 18 Novartis Ag: Financial Overview Snapshot
- Figure 19 Novartis Ag: Swot Analysis
- Figure 20 Sun Pharmaceutical Industries Ltd.: Swot Analysis
- Figure 21 Bristol-myers Squibb Company: Financial Overview
- Figure 22 Bristol-myers Squibb Company: Swot Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook